Lortye Sera, Will Joanne P, Marquenie Loes A, Lommerse Nick M, Faber Nathalie, Goudriaan Anna E, Arntz Arnoud, de Waal Marleen M
Arkin Mental Health Care, Jellinek, Amsterdam Institute for Addiction Research, Amsterdam, the Netherlands.
Department of Research, Arkin Mental Health Care, Amsterdam, the Netherlands.
Addiction. 2025 May 29. doi: 10.1111/add.70097.
Post-traumatic stress disorder (PTSD) and substance use disorder (SUD) are highly co-occurring and evidence for the optimal ways of treating PTSD in SUD patients is mixed. Our aim was to compare three different PTSD treatments, each added simultaneously to SUD treatment, with SUD treatment alone in patients with co-occurring SUD-PTSD. These PTSD treatments were: Prolonged Exposure (PE), Eye Movement Desensitization and Reprocessing (EMDR) and Imagery Rescripting (ImRs).
A single-blind 4-arm randomized controlled trial with follow-up at 3 months.
Two addiction treatment centers in the Netherlands, providing intra- and extramural care.
209 patients with SUD and co-morbid PTSD were included [mean age 37.5 (standard deviation, SD = 11.99), female sex = 46.4%, mean Clinically Administered PTSD Scale (CAPS) score = 37.35 (SD = 9.28)].
Participants were randomized to either simultaneous SUD + PE (n = 53), SUD + EMDR (n = 50), SUD + ImRs (n = 55) or to SUD treatment only (n = 51), with the active PTSD treatments consisting of 12 sessions each within 3 months. Standard protocols were used.
The primary outcome was clinician-administered PTSD symptom severity as measured by Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (CAPS-5) at 3 month follow-up. Secondary outcomes included loss of PTSD diagnosis, full remission of PSTD and SUD-severity, also recorded at 3 months.
Compared with SUD only, the mean differences in CAPS-5 score were B = -5.41 [95% confidence interval (CI) = 10.88, 0.05, P = 0.052] for SUD + PE, B = -7.97 (95% CI = -13.57, -2.37, P = 0.006) for SUD + EMDR and B = -10.03 (95% CI = -15.29, -4.77, P < 0.001) for SUD + ImRs. When adjusted for baseline covariates, mean differences were B = -5.81 (95% CI = -11.48, -0.15, P = 0.044) for SUD + PE, B = -8.85 (95% CI = -14.60, -3.10, P = 0.003) for SUD + EMDR and B = -10.75 (95% CI = -15.94, -5.56, P = <0.001) for SUD + ImRs. No between-group differences in SUD outcomes were found.
Among people with co-occurring substance use disorder (SUD) and post-traumatic stress disorder (PTSD), trauma-focused PTSD treatment as add-on to SUD treatment appears to be effective in decreasing PTSD severity compared with manualized SUD only treatment and does not appear to increase SUD severity.
创伤后应激障碍(PTSD)与物质使用障碍(SUD)高度共病,且关于SUD患者中治疗PTSD的最佳方法的证据不一。我们的目的是比较三种不同的PTSD治疗方法(每种方法同时添加到SUD治疗中)与仅进行SUD治疗,对共病SUD-PTSD患者的效果。这些PTSD治疗方法分别是:延长暴露疗法(PE)、眼动脱敏再处理疗法(EMDR)和意象重编疗法(ImRs)。
一项单盲四臂随机对照试验,随访3个月。
荷兰的两个成瘾治疗中心,提供院内和院外护理。
纳入209例患有SUD且合并PTSD的患者[平均年龄37.5岁(标准差,SD = 11.99),女性占46.4%,临床管理的PTSD量表(CAPS)平均得分 = 37.35(SD = 9.28)]。
参与者被随机分为同时接受SUD + PE治疗组(n = 53)、SUD + EMDR治疗组(n = 50)、SUD + ImRs治疗组(n = 55)或仅接受SUD治疗组(n = 51),三种积极的PTSD治疗方法均在3个月内各进行12次治疗。采用标准方案。
主要结局是在3个月随访时,由临床医生根据《精神疾病诊断与统计手册》第五版(CAPS-5)评估的PTSD症状严重程度。次要结局包括PTSD诊断消失、PTSD和SUD完全缓解,同样在3个月时记录。
与仅接受SUD治疗相比,SUD + PE组CAPS-5评分的平均差异为B = -5.41 [95%置信区间(CI)= 10.88, 0.05, P = 0.052],SUD + EMDR组为B = -7.97(95% CI = -13.57, -2.37, P = 0.006),SUD + ImRs组为B = -10.03(95% CI = -15.29, -4.77, P < 0.001)。在对基线协变量进行调整后,SUD + PE组的平均差异为B = -5.81(95% CI = -11.48, -0.15, P = 0.044),SUD + EMDR组为B = -8.85(95% CI = -14.60, -3.10, P = 0.003),SUD + ImRs组为B = -10.75(95% CI = -15.94, -5.56, P = <0.001)。未发现各组在SUD结局方面存在差异。
在共病物质使用障碍(SUD)和创伤后应激障碍(PTSD)的患者中,与仅进行标准化SUD治疗相比,在SUD治疗基础上增加针对创伤的PTSD治疗似乎能有效降低PTSD严重程度,且似乎不会增加SUD严重程度。